"A cancer diagnosis can come as a shock, making you feel overwhelmed, scared and helpless. Knowing what to expect can help alleviate some of these feelings. Very few cancers require emergency treatment, so take some time to learn about your diagnosis and treatment options, and ask questions. If youre not already a patient, we invite you to see us for a second opinion."

During the past decade, Willamette Valley Cancer Institute and Research Center conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 67 clinical trials were completed, i.e. on average, 78.8% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 30 clinical trials were completed. i.e. 88.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Willamette Valley Cancer Institute and Research Center" #1 sponsor was "Radiation Therapy Oncology Group" with 14 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "US Oncology Research" with 10 trials sponsored, "Seagen Inc." with 9 trials sponsored and "Bristol-Myers Squibb" with 9 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Willamette Valley Cancer Institute and Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Bristol-Myers Squibb" with 8 trials as a collaborator, "GOG Foundation" with 6 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 5 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Willamette Valley Cancer Institute and Research Center" are "Breast Cancer" (11 trials), "Chronic Lymphocytic Leukemia" (11 trials), "Ovarian Cancer" (11 trials), "Multiple Myeloma" (8 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Willamette Valley Cancer Institute and Research Center" in a lesser frequency.

Most popular intervention types in "Willamette Valley Cancer Institute and Research Center" are "Drug" (138 trials), "Radiation" (22 trials), "Biological" (21 trials), "Other" (21 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (12 trials), "Rituximab" (12 trials), "Paclitaxel" (10 trials) and "Atezolizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Willamette Valley Cancer Institute and Research Center" are 113 trials for "All" genders, 36 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Willamette Valley Cancer Institute and Research Center". undefined are not yet recruiting, 24 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Willamette Valley Cancer Institute and Research Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Willamette Valley Cancer Institute and Research Center, 31 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Willamette Valley Cancer Institute and Research Center has several departments that took part in Clinical trials: "Willamette Valley Cancer Ctr - 520 Country Club" - 9 trials